StephanieAnnLeonardMD

Allergy & Immunology • San Diego, CA

Associate Professor, Pediatrics, UC San Diego Sch. of Medicine

Join to view full profile

Dr. Leonard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leonard's full profile

Already have an account?

Office
8110 Birmingham Way
Bldg 28
San Diego, CA 92123
Phone+1 858-966-5961

Fax+1 858-309-6301

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 2008 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2005 - 2008
Columbia University Vagelos College of Physicians and SurgeonsClass of 2005

Certifications & Licensure

CA State Medical License 2011 - 2025
NY State Medical License 2007 - 2012
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Clinical Trials

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy Start of enrollment: 2012 Aug 01
Completed
Phase 2
Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children Start of enrollment: 2013 Sep 01
Completed
Phase 2
Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT Start of enrollment: 2014 Feb 06
Completed
Phase 2
Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study Start of enrollment: 2014 Aug 27
Completed
Phase 2
Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Start of enrollment: 2014 Nov 01
Completed
Phase 1, Phase 2
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) Start of enrollment: 2015 Dec 22
Completed
Phase 3
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy Start of enrollment: 2015 Dec 01
Completed
Phase 3
PALISADE Follow-on Study (ARC004) Start of enrollment: 2016 Dec 29
Completed
Phase 3
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children Start of enrollment: 2017 Jan 23
Active, not recruiting
Phase 3
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age Start of enrollment: 2017 Jul 31
Active, not recruiting
Phase 3
Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) Start of enrollment: 2017 Oct 11
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Assessing protocol variability for food protein-induced enterocolitis syndrome oral food challenges.
Sara Anvari, Ankona Banerjee, Stephanie Leonard, Purificacion Gonzalez-Delgado, Duc T Nguyen
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-01
Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting.
Anna Nowak-Wegrzyn, Scott H Sicherer, Cem Akin, Sara Anvari, Lisa M Bartnikas
The Journal of Allergy and Clinical Immunology. 2025-02-01
10 practical priorities to prevent and manage serious allergic reactions: GALEN ANACare and EFA Anaphylaxis Manifesto.
Antonella Muraro, Debra de Silva, Marcia Podesta, Aikaterini Anagnostou, Victoria Cardona
Clinical and Translational Allergy. 2024-12-01

Press Mentions

Birthing Mothers with Mother Partners Experience Disparities in Birth-Related OutcomesApril 13th, 2022
The Family of Two Mothers Faces a Large Disparity in the Outcome of Their PregnancyApril 7th, 2022
First Edition: March 29, 2022March 29th, 2022
Join now to see all

StephanieAnnLeonardMD

Dr. Leonard is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.